Balanced news tone
News Sentiment
INIFY sentiment intelligence
INIFY Laboratories AB news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
3 relevant articles
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +121.0% over four weeks, trend active, and near fair-value range.
CapEx per share of INIFY Laboratories AB – OSL:INIFY
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
78/100 classification
One-week reaction
0.0%
Price digesting
Trend fit
Trend active
121.0% over four weeks
Fair value
4.3%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
1
Neutral
2
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TradingView
Direct company coverage
CapEx per share of INIFY Laboratories AB – OSL:INIFY
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 02:08
- Source
- TradingView
Finansavisen
Direct company coverage
Inify Laboratories AB: Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 13:13
- Source
- Finansavisen
Finansavisen
Direct company coverage
Inify Laboratories AB: Inify Laboratories: Progress in the dialogue with NHS in the UK and continued growth in Sweden
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- Finansavisen